Trial Outcomes & Findings for Involving Family to Improve Communication in Breast Cancer Care (NCT NCT03283553)
NCT ID: NCT03283553
Last Updated: 2021-03-19
Results Overview
Illness understanding was measured by 4 questions regarding knowledge that is considered to be essential to making informed treatment decisions in serious illness, including: 1.) understanding of illness, 2.) knowledge of disease status, 3.) awareness of disease state, and 4.) expectation of duration of life. We summed responses to each item (coded 1 or 0 to reflect the presence or absence of understanding), yielding a score ranging from 0 to 4. Participants with perfect scores reflecting complete illness understanding (4 of 4 correct responses) were compared to all others.
COMPLETED
NA
132 participants
9 months
2021-03-19
Participant Flow
Patients of participating clinicians who were in active treatment for early stage or advanced breast cancer were mailed letters describing the study 3 weeks before their next scheduled visit. Patients who did not "opt out" by mail were contacted by research staff to discuss study procedures and administer a screening interview.
Participant milestones
| Measure |
Multicomponent Intervention
1.) A one-page paper-pencil agenda setting checklist completed immediately before a regularly scheduled medical oncology visit to elicit and align patient and companion perspectives regarding issues to discuss with the provider, and to stimulate discussion about the role of the companion in the visit, 2.) facilitated registration for the patient portal (for patient and family member, as desired by the patient), and 3.) education (as relevant) on access to doctor's electronic visit notes.
|
Usual Care
Care as usual with the medical oncologist.
|
|---|---|---|
|
Patient Participant Flow
STARTED
|
69
|
63
|
|
Patient Participant Flow
Patient Baseline Interview
|
69
|
62
|
|
Patient Participant Flow
Patient 3-Month Interview
|
67
|
60
|
|
Patient Participant Flow
Patient 9-Month Interview
|
63
|
57
|
|
Patient Participant Flow
Patient 12-Month Interview
|
59
|
50
|
|
Patient Participant Flow
COMPLETED
|
59
|
50
|
|
Patient Participant Flow
NOT COMPLETED
|
10
|
13
|
|
Care Partner Participant Flow
STARTED
|
69
|
63
|
|
Care Partner Participant Flow
Care Partner Baseline Interview
|
69
|
63
|
|
Care Partner Participant Flow
Care Partner 3-Month Interview
|
69
|
60
|
|
Care Partner Participant Flow
Care Partner 9-Month Interview
|
64
|
55
|
|
Care Partner Participant Flow
Care Partner 12-Month Interview
|
59
|
48
|
|
Care Partner Participant Flow
COMPLETED
|
59
|
48
|
|
Care Partner Participant Flow
NOT COMPLETED
|
10
|
15
|
Reasons for withdrawal
| Measure |
Multicomponent Intervention
1.) A one-page paper-pencil agenda setting checklist completed immediately before a regularly scheduled medical oncology visit to elicit and align patient and companion perspectives regarding issues to discuss with the provider, and to stimulate discussion about the role of the companion in the visit, 2.) facilitated registration for the patient portal (for patient and family member, as desired by the patient), and 3.) education (as relevant) on access to doctor's electronic visit notes.
|
Usual Care
Care as usual with the medical oncologist.
|
|---|---|---|
|
Patient Participant Flow
Death
|
5
|
10
|
|
Patient Participant Flow
Withdrawal by Subject
|
4
|
2
|
|
Patient Participant Flow
Lost to Follow-up
|
1
|
1
|
|
Care Partner Participant Flow
Withdrawal by Subject
|
4
|
3
|
|
Care Partner Participant Flow
Lost to Follow-up
|
1
|
1
|
|
Care Partner Participant Flow
Discontinued because patient death
|
5
|
11
|
Baseline Characteristics
Involving Family to Improve Communication in Breast Cancer Care
Baseline characteristics by cohort
| Measure |
Multicomponent Intervention
n=69 Participants
1.) A one-page paper-pencil agenda setting checklist completed immediately before a regularly scheduled medical oncology visit to elicit and align patient and companion perspectives regarding issues to discuss with the provider, and to stimulate discussion about the role of the companion in the visit, 2.) facilitated registration for the patient portal (for patient and family member, as desired by the patient), and 3.) education (as relevant) on access to doctor's electronic visit notes.
|
Usual Care
n=63 Participants
Care as usual with the medical oncologist.
|
Total
n=132 Participants
Total of all reporting groups
|
|---|---|---|---|
|
Age, Continuous
Patient age
|
55.1 years
STANDARD_DEVIATION 13.4 • n=5 Participants
|
52.9 years
STANDARD_DEVIATION 14.5 • n=7 Participants
|
54.1 years
STANDARD_DEVIATION 13.9 • n=5 Participants
|
|
Age, Continuous
Care Partner age
|
54.0 years
STANDARD_DEVIATION 13.79 • n=5 Participants
|
54.0 years
STANDARD_DEVIATION 13.5 • n=7 Participants
|
54 years
STANDARD_DEVIATION 13.61 • n=5 Participants
|
|
Sex: Female, Male
Patient sex · Female
|
68 Participants
n=5 Participants
|
63 Participants
n=7 Participants
|
131 Participants
n=5 Participants
|
|
Sex: Female, Male
Patient sex · Male
|
1 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
1 Participants
n=5 Participants
|
|
Sex: Female, Male
Care Partner sex · Female
|
28 Participants
n=5 Participants
|
18 Participants
n=7 Participants
|
46 Participants
n=5 Participants
|
|
Sex: Female, Male
Care Partner sex · Male
|
41 Participants
n=5 Participants
|
45 Participants
n=7 Participants
|
86 Participants
n=5 Participants
|
|
Ethnicity (NIH/OMB)
Patient Ethnicity · Hispanic or Latino
|
4 Participants
n=5 Participants
|
3 Participants
n=7 Participants
|
7 Participants
n=5 Participants
|
|
Ethnicity (NIH/OMB)
Patient Ethnicity · Not Hispanic or Latino
|
64 Participants
n=5 Participants
|
60 Participants
n=7 Participants
|
124 Participants
n=5 Participants
|
|
Ethnicity (NIH/OMB)
Patient Ethnicity · Unknown or Not Reported
|
1 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
1 Participants
n=5 Participants
|
|
Ethnicity (NIH/OMB)
Care Partner Ethnicity · Hispanic or Latino
|
2 Participants
n=5 Participants
|
3 Participants
n=7 Participants
|
5 Participants
n=5 Participants
|
|
Ethnicity (NIH/OMB)
Care Partner Ethnicity · Not Hispanic or Latino
|
65 Participants
n=5 Participants
|
60 Participants
n=7 Participants
|
125 Participants
n=5 Participants
|
|
Ethnicity (NIH/OMB)
Care Partner Ethnicity · Unknown or Not Reported
|
2 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
2 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Patient Race · American Indian or Alaska Native
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Patient Race · Asian
|
1 Participants
n=5 Participants
|
2 Participants
n=7 Participants
|
3 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Patient Race · Native Hawaiian or Other Pacific Islander
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Patient Race · Black or African American
|
12 Participants
n=5 Participants
|
14 Participants
n=7 Participants
|
26 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Patient Race · White
|
55 Participants
n=5 Participants
|
44 Participants
n=7 Participants
|
99 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Patient Race · More than one race
|
1 Participants
n=5 Participants
|
3 Participants
n=7 Participants
|
4 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Patient Race · Unknown or Not Reported
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Care Partner Race · American Indian or Alaska Native
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Care Partner Race · Asian
|
1 Participants
n=5 Participants
|
3 Participants
n=7 Participants
|
4 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Care Partner Race · Native Hawaiian or Other Pacific Islander
|
0 Participants
n=5 Participants
|
1 Participants
n=7 Participants
|
1 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Care Partner Race · Black or African American
|
11 Participants
n=5 Participants
|
16 Participants
n=7 Participants
|
27 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Care Partner Race · White
|
55 Participants
n=5 Participants
|
40 Participants
n=7 Participants
|
95 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Care Partner Race · More than one race
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Care Partner Race · Unknown or Not Reported
|
2 Participants
n=5 Participants
|
3 Participants
n=7 Participants
|
5 Participants
n=5 Participants
|
|
Region of Enrollment
United States
|
69 Participants
n=5 Participants
|
63 Participants
n=7 Participants
|
132 Participants
n=5 Participants
|
|
Breast Cancer Disease Stage
Early Stage Breast Cancer
|
35 Participants
n=5 Participants
|
37 Participants
n=7 Participants
|
72 Participants
n=5 Participants
|
|
Breast Cancer Disease Stage
Metastatic Breast Cancer
|
34 Participants
n=5 Participants
|
26 Participants
n=7 Participants
|
60 Participants
n=5 Participants
|
PRIMARY outcome
Timeframe: 9 monthsPopulation: The analysis sample includes the 118 patient-care-partner dyads with complete assessments at 9-months.
Illness understanding was measured by 4 questions regarding knowledge that is considered to be essential to making informed treatment decisions in serious illness, including: 1.) understanding of illness, 2.) knowledge of disease status, 3.) awareness of disease state, and 4.) expectation of duration of life. We summed responses to each item (coded 1 or 0 to reflect the presence or absence of understanding), yielding a score ranging from 0 to 4. Participants with perfect scores reflecting complete illness understanding (4 of 4 correct responses) were compared to all others.
Outcome measures
| Measure |
Multicomponent Intervention
n=63 Participants
1.) A one-page paper-pencil agenda setting checklist completed immediately before a regularly scheduled medical oncology visit to elicit and align patient and companion perspectives regarding issues to discuss with the provider, and to stimulate discussion about the role of the companion in the visit, 2.) facilitated registration for the patient portal (for patient and family member, as desired by the patient), and 3.) education (as relevant) on access to doctor's electronic visit notes.
|
Usual Care
n=55 Participants
Care as usual with the medical oncologist.
|
|---|---|---|
|
Between-group Differences in Patient Complete Illness Understanding at 9-months
Complete Illness Understanding at 9-Months
|
42 Participants
|
38 Participants
|
|
Between-group Differences in Patient Complete Illness Understanding at 9-months
Not Complete Illness Understanding at 9-Months
|
21 Participants
|
17 Participants
|
PRIMARY outcome
Timeframe: 9 monthsPopulation: The analysis sample includes the 118 patient-care-partner dyads with complete assessments at 9-months.
Outcome was measured with the short-form 10-item version of the Family Satisfaction with Cancer Care (FAMCARE) questionnaire, a validated multi-item instrument that was developed to assess family perspective on cancer care. Respondents are asked to rate 10 items that relate to emotional support, personalization of care, support of decision-making, accessibility, and coordination. Response categories include "very satisfied" (2 points), "satisfied" (1 point), or "not satisfied" (0 points), and the 10-items may be summed to yield a total score (range: 0 to 20) with higher scores reflecting greater satisfaction.
Outcome measures
| Measure |
Multicomponent Intervention
n=63 Participants
1.) A one-page paper-pencil agenda setting checklist completed immediately before a regularly scheduled medical oncology visit to elicit and align patient and companion perspectives regarding issues to discuss with the provider, and to stimulate discussion about the role of the companion in the visit, 2.) facilitated registration for the patient portal (for patient and family member, as desired by the patient), and 3.) education (as relevant) on access to doctor's electronic visit notes.
|
Usual Care
n=55 Participants
Care as usual with the medical oncologist.
|
|---|---|---|
|
Between-group Differences in Mean Patient Satisfaction With Cancer Care at 9-months
|
16.9 score on a scale
Standard Deviation 3.9
|
15.4 score on a scale
Standard Deviation 5.4
|
PRIMARY outcome
Timeframe: 9 monthsPopulation: The analysis sample includes the 118 patient-care-partner dyads with complete assessments at 9-months.
Outcome was measured using the Generalized Anxiety Disorder 2-item questionnaire (GAD-2), a well-established 2-item instrument that asks about symptoms of anxiety in a two-week recall period from 0 ("not at all") to 3 ("nearly every day"). Full range is 0-6 with higher scores indicating more anxiety. Symptoms of anxiety refer to a cutpoint of 3+ on the GAD-2.
Outcome measures
| Measure |
Multicomponent Intervention
n=63 Participants
1.) A one-page paper-pencil agenda setting checklist completed immediately before a regularly scheduled medical oncology visit to elicit and align patient and companion perspectives regarding issues to discuss with the provider, and to stimulate discussion about the role of the companion in the visit, 2.) facilitated registration for the patient portal (for patient and family member, as desired by the patient), and 3.) education (as relevant) on access to doctor's electronic visit notes.
|
Usual Care
n=55 Participants
Care as usual with the medical oncologist.
|
|---|---|---|
|
Between-group Differences in Patient Anxiety at 9-months
Symptoms of Anxiety at 9-Months
|
7 Participants
|
8 Participants
|
|
Between-group Differences in Patient Anxiety at 9-months
No Symptoms of Anxiety at 9-Months
|
56 Participants
|
47 Participants
|
PRIMARY outcome
Timeframe: 9 monthsPopulation: The analysis sample includes the 118 patient-care-partner dyads with complete assessments at 9-months.
Illness understanding was measured by 4 questions regarding knowledge that is considered to be essential to making informed treatment decisions in serious illness, including: 1.) understanding of illness, 2.) knowledge of disease status, 3.) awareness of disease state, and 4.) expectation of duration of life. We summed responses to each item (coded 1 or 0 to reflect the presence or absence of understanding), yielding a score ranging from 0 to 4. Participants with perfect scores reflecting complete illness understanding (4 of 4 correct responses) were compared to all others.
Outcome measures
| Measure |
Multicomponent Intervention
n=63 Participants
1.) A one-page paper-pencil agenda setting checklist completed immediately before a regularly scheduled medical oncology visit to elicit and align patient and companion perspectives regarding issues to discuss with the provider, and to stimulate discussion about the role of the companion in the visit, 2.) facilitated registration for the patient portal (for patient and family member, as desired by the patient), and 3.) education (as relevant) on access to doctor's electronic visit notes.
|
Usual Care
n=55 Participants
Care as usual with the medical oncologist.
|
|---|---|---|
|
Between-group Differences in Care Partner Complete Illness Understanding at 9-months
Not Complete Illness Understanding at 9-Months
|
19 Participants
|
16 Participants
|
|
Between-group Differences in Care Partner Complete Illness Understanding at 9-months
Complete Illness Understanding at 9-Months
|
44 Participants
|
39 Participants
|
PRIMARY outcome
Timeframe: 9 monthsPopulation: The analysis sample includes the 118 patient-care-partner dyads with complete assessments at 9-months.
Outcome was measured with the short-form 10-item version of the FAMCARE (Family Satisfaction with Cancer Care) questionnaire, a validated multi-item instrument that was developed to assess family perspective on cancer care. Respondents are asked to rate 10 items that relate to emotional support, personalization of care, support of decision-making, accessibility, and coordination. Response categories include "very satisfied" (2 points), "satisfied" (1 point), or "not satisfied" (0 points), and the 10-items may be summed to yield a total score (range: 0 to 20) with higher scores reflecting greater satisfaction.
Outcome measures
| Measure |
Multicomponent Intervention
n=63 Participants
1.) A one-page paper-pencil agenda setting checklist completed immediately before a regularly scheduled medical oncology visit to elicit and align patient and companion perspectives regarding issues to discuss with the provider, and to stimulate discussion about the role of the companion in the visit, 2.) facilitated registration for the patient portal (for patient and family member, as desired by the patient), and 3.) education (as relevant) on access to doctor's electronic visit notes.
|
Usual Care
n=55 Participants
Care as usual with the medical oncologist.
|
|---|---|---|
|
Between-group Differences in Care Partner Satisfaction With Cancer Care at 9-months
|
15.7 score on a scale
Standard Deviation 4.4
|
15.4 score on a scale
Standard Deviation 5.5
|
PRIMARY outcome
Timeframe: 9 monthsPopulation: The analysis sample includes the 118 patient-care-partner dyads with complete assessments at 9-months.
Outcome was measured using the Generalized Anxiety Disorder 2-item questionnaire (GAD-2), a well-established 2-item instrument that asks about symptoms of anxiety in a two-week recall period from 0 ("not at all") to 3 ("nearly every day"). Full range is 0-6 with higher scores indicating more anxiety. Symptoms of anxiety refer to a cutpoint of 3+ on the GAD-2.
Outcome measures
| Measure |
Multicomponent Intervention
n=63 Participants
1.) A one-page paper-pencil agenda setting checklist completed immediately before a regularly scheduled medical oncology visit to elicit and align patient and companion perspectives regarding issues to discuss with the provider, and to stimulate discussion about the role of the companion in the visit, 2.) facilitated registration for the patient portal (for patient and family member, as desired by the patient), and 3.) education (as relevant) on access to doctor's electronic visit notes.
|
Usual Care
n=55 Participants
Care as usual with the medical oncologist.
|
|---|---|---|
|
Between-group Differences in Care Partner Anxiety at 9-months
Symptoms of Anxiety at 9-Months
|
8 Participants
|
10 Participants
|
|
Between-group Differences in Care Partner Anxiety at 9-months
No Symptoms of Anxiety at 9-Months
|
55 Participants
|
45 Participants
|
SECONDARY outcome
Timeframe: 9 monthsPopulation: The analysis sample includes the 118 patient-care-partner dyads with complete assessments at 9-months.
Outcome was measured using the Quality of Communication (QC) Scale, a validated 10-item instrument to assess quality of communication between the participant and the medical oncology team. The scale for each item is from 0 ('Worst you can imagine') to 10 ('Best you can imagine'). Full range is 0-100 with higher scores indicating higher perceived quality of communication.
Outcome measures
| Measure |
Multicomponent Intervention
n=63 Participants
1.) A one-page paper-pencil agenda setting checklist completed immediately before a regularly scheduled medical oncology visit to elicit and align patient and companion perspectives regarding issues to discuss with the provider, and to stimulate discussion about the role of the companion in the visit, 2.) facilitated registration for the patient portal (for patient and family member, as desired by the patient), and 3.) education (as relevant) on access to doctor's electronic visit notes.
|
Usual Care
n=55 Participants
Care as usual with the medical oncologist.
|
|---|---|---|
|
Between-group Differences in Patient Quality of Communication at 9-months
|
89.8 units on a scale
Standard Deviation 11.6
|
88.0 units on a scale
Standard Deviation 18.7
|
SECONDARY outcome
Timeframe: 9 monthsPopulation: The analysis sample includes the 118 patient-care-partner dyads with complete assessments at 9-months.
Outcome was measured using the Quality of Communication (QC) Scale, a validated 10-item instrument to assess quality of communication between the participant and the medical oncology team. The scale for each item is from 0 ('Worst you can imagine') to 10 ('Best you can imagine'). Full range is 0-100 with higher scores indicating higher perceived quality of communication.
Outcome measures
| Measure |
Multicomponent Intervention
n=63 Participants
1.) A one-page paper-pencil agenda setting checklist completed immediately before a regularly scheduled medical oncology visit to elicit and align patient and companion perspectives regarding issues to discuss with the provider, and to stimulate discussion about the role of the companion in the visit, 2.) facilitated registration for the patient portal (for patient and family member, as desired by the patient), and 3.) education (as relevant) on access to doctor's electronic visit notes.
|
Usual Care
n=55 Participants
Care as usual with the medical oncologist.
|
|---|---|---|
|
Between-group Differences in Care Partner Quality of Communication at 9-months
|
90.3 units on a scale
Standard Deviation 10.3
|
86.2 units on a scale
Standard Deviation 15.9
|
POST_HOC outcome
Timeframe: 9 monthsPopulation: The analysis sample includes the 118 patient-care-partner dyads with complete assessments at 9-months.
Care partner registration for shared access to the patient portal was assessed at baseline and nine-months post-enrollment.
Outcome measures
| Measure |
Multicomponent Intervention
n=63 Participants
1.) A one-page paper-pencil agenda setting checklist completed immediately before a regularly scheduled medical oncology visit to elicit and align patient and companion perspectives regarding issues to discuss with the provider, and to stimulate discussion about the role of the companion in the visit, 2.) facilitated registration for the patient portal (for patient and family member, as desired by the patient), and 3.) education (as relevant) on access to doctor's electronic visit notes.
|
Usual Care
n=55 Participants
Care as usual with the medical oncologist.
|
|---|---|---|
|
Between-group Differences in Care Partner Registration for Shared Access to the Patient Portal at 9-months
Care Partner Registered by 9 Months
|
49 Participants
|
1 Participants
|
|
Between-group Differences in Care Partner Registration for Shared Access to the Patient Portal at 9-months
Care Partner Did Not Register by 9 Months
|
14 Participants
|
54 Participants
|
POST_HOC outcome
Timeframe: 9 monthsPopulation: The analysis sample includes the patients who used a patient portal feature at least once during 9 month follow up period.
Patient portal use was assessed from date and time-stamped interactions reflecting the frequency, timing, and type of patient portal interactions.Use of the patient portal refers to interactions between enrollment and up to 40-weeks post-enrollment.
Outcome measures
| Measure |
Multicomponent Intervention
n=60 Participants
1.) A one-page paper-pencil agenda setting checklist completed immediately before a regularly scheduled medical oncology visit to elicit and align patient and companion perspectives regarding issues to discuss with the provider, and to stimulate discussion about the role of the companion in the visit, 2.) facilitated registration for the patient portal (for patient and family member, as desired by the patient), and 3.) education (as relevant) on access to doctor's electronic visit notes.
|
Usual Care
n=50 Participants
Care as usual with the medical oncologist.
|
|---|---|---|
|
Between-group Differences in Patient Views of Clinical Visit Notes in the Patient Portal at 9-months
Patient Viewed a Clinical Visit Note by 9-months
|
38 Participants
|
18 Participants
|
|
Between-group Differences in Patient Views of Clinical Visit Notes in the Patient Portal at 9-months
Patient Did Not View a Clinical Visit Note by 9-months
|
22 Participants
|
32 Participants
|
POST_HOC outcome
Timeframe: 9 monthsPopulation: The analysis sample includes the care partners who logged in to the patient portal at least once during 9 month follow up period.
Patient portal use was assessed from date and time-stamped interactions reflecting the frequency, timing, and type of patient portal interactions. Use of the patient portal refers to interactions between enrollment and up to 40-weeks post-enrollment.
Outcome measures
| Measure |
Multicomponent Intervention
n=49 Participants
1.) A one-page paper-pencil agenda setting checklist completed immediately before a regularly scheduled medical oncology visit to elicit and align patient and companion perspectives regarding issues to discuss with the provider, and to stimulate discussion about the role of the companion in the visit, 2.) facilitated registration for the patient portal (for patient and family member, as desired by the patient), and 3.) education (as relevant) on access to doctor's electronic visit notes.
|
Usual Care
n=1 Participants
Care as usual with the medical oncologist.
|
|---|---|---|
|
Between-group Differences in Care Partner Views of Clinical Visit Notes in the Patient Portal at 9-months
Care Partner Viewed a Clinical Visit Note by 9-months
|
30 Participants
|
0 Participants
|
|
Between-group Differences in Care Partner Views of Clinical Visit Notes in the Patient Portal at 9-months
Care Partner Did Not View a Clinical Visit Note by 9-months
|
19 Participants
|
1 Participants
|
POST_HOC outcome
Timeframe: 9 monthsPopulation: The analysis sample includes the patients who logged in to the patient portal at least once during 9 month follow up period.
Patient portal use was assessed from date and time-stamped interactions reflecting the frequency, timing, and type of patient portal interactions. Use of the patient portal refers to interactions between enrollment and up to 40-weeks post-enrollment.
Outcome measures
| Measure |
Multicomponent Intervention
n=60 Participants
1.) A one-page paper-pencil agenda setting checklist completed immediately before a regularly scheduled medical oncology visit to elicit and align patient and companion perspectives regarding issues to discuss with the provider, and to stimulate discussion about the role of the companion in the visit, 2.) facilitated registration for the patient portal (for patient and family member, as desired by the patient), and 3.) education (as relevant) on access to doctor's electronic visit notes.
|
Usual Care
n=50 Participants
Care as usual with the medical oncologist.
|
|---|---|---|
|
Between-group Differences in Patient Exchange of Direct Messages in the Patient Portal at 9-months
Patient Exchanged a Direct Message by 9-months
|
52 Participants
|
38 Participants
|
|
Between-group Differences in Patient Exchange of Direct Messages in the Patient Portal at 9-months
Patient Did Not Exchange a Direct Message by 9-months
|
8 Participants
|
12 Participants
|
POST_HOC outcome
Timeframe: 9 monthsPopulation: The analysis sample includes the care partners who logged in to the patient portal at least once during 9 month follow up period.
Patient portal use was assessed from date and time-stamped interactions reflecting the frequency, timing, and type of patient portal interactions. Use of the patient portal refers to interactions between enrollment and up to 40-weeks post-enrollment.
Outcome measures
| Measure |
Multicomponent Intervention
n=49 Participants
1.) A one-page paper-pencil agenda setting checklist completed immediately before a regularly scheduled medical oncology visit to elicit and align patient and companion perspectives regarding issues to discuss with the provider, and to stimulate discussion about the role of the companion in the visit, 2.) facilitated registration for the patient portal (for patient and family member, as desired by the patient), and 3.) education (as relevant) on access to doctor's electronic visit notes.
|
Usual Care
n=1 Participants
Care as usual with the medical oncologist.
|
|---|---|---|
|
Between-group Differences in Care Partner Exchange of Direct Messages in the Patient Portal at 9-months
Care Partner Exchanged a Direct Message by 9-months
|
3 Participants
|
0 Participants
|
|
Between-group Differences in Care Partner Exchange of Direct Messages in the Patient Portal at 9-months
Care Partner Did Not Exchange a Direct Message by 9-months
|
46 Participants
|
1 Participants
|
Adverse Events
Multicomponent Intervention
Usual Care
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place